Live Breaking News & Updates on Relay Therapeutics Company Profile

Stay updated with breaking news from Relay therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Relay Therapeutics (NASDAQ:RLAY) Shares Down 6.5%

Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report)’s share price fell 6.5% during trading on Wednesday . The stock traded as low as $6.29 and last traded at $6.33. 68,135 shares traded hands during trading, a decline of 94% from the average session volume of 1,156,340 shares. The stock had previously closed at $6.77. Analyst […] ....

Switzerland , Swiss , Stifel-nicolaus , Leerink-partnrs , Relay-therapeutics-inc , Nasdaq , Barclays , Relay-therapeutics-company-profile , Swiss-national-bank , Charles-schwab-investment-management-inc , Principal-financial-group-inc , T-bank-corp

Relay Therapeutics (NASDAQ:RLAY) Upgraded to Overweight at Barclays

Relay Therapeutics (NASDAQ:RLAY) Upgraded to Overweight at Barclays
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Leerink-partnrs , Stifel-nicolaus , Relay-therapeutics-company-profile , Norges-bank , Bellevue-group , Vanguard-group-inc , Relay-therapeutics-inc , Barclays , Relay-therapeutics , Free-report , Get-free-report , Finepoint-capital

Relay Therapeutics (NASDAQ:RLAY) Raised to "Overweight" at Barclays

Relay Therapeutics (NASDAQ:RLAY) Raised to "Overweight" at Barclays
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Stifel-nicolaus , Leerink-partnrs , Relay-therapeutics-company-profile , Relay-therapeutics-inc , Norges-bank , Barclays , Affinity-asset-advisors , Bellevue-group , Nasdaq , Relay-therapeutics , Get-free-report , Therapeutics-stock-down

Relay Therapeutics (NASDAQ:RLAY) Receives "Outperform" Rating from Oppenheimer

Relay Therapeutics (NASDAQ:RLAY) Receives "Outperform" Rating from Oppenheimer
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Stifel-nicolaus , Leerink-partnrs , Relay-therapeutics-company-profile , Norges-bank , Affinity-asset-advisors , Relay-therapeutics-inc , Bellevue-group , Relay-therapeutics , Free-report , Get-free-report , Relay-therapeutics-daily ,

Relay Therapeutics (NASDAQ:RLAY) Trading Down 5.2%

Relay Therapeutics (NASDAQ:RLAY) Trading Down 5.2%
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Stifel-nicolaus , Leerink-partnrs , Bellevue-group , Norges-bank , Vanguard-group-inc , Relay-therapeutics-inc , Relay-therapeutics-company-profile , Nasdaq , Relay-therapeutics , Get-free-report , Finepoint-capital , Relay-therapeutics-daily